Risultati di ricerca
Sir Christopher Charles Gent HonFREng (born 10 May 1948) is a British businessman, He is the former chief executive officer of Vodafone, a British multinational mobile phone company. Until 2015, he served as the non-exec chairman of GlaxoSmithKline, the world's fourth largest pharmaceutical company.
5 ago 2022 · These glittering achievements now lie in tatters, perhaps, after the Financial Conduct Authority fined Gent £80,000 for acting “negligently” with inside information. His misdemeanour was to ...
- Bryce Elder
5 ago 2022 · Share Publication. On 5 August 2022, the FCA issued a final notice against Sir Christopher Gent, the former non-executive Chair of ConvaTec Group Plc (the Company), fining him £80,000 for committing market abuse by unlawfully disclosing inside information.
5 ago 2022 · The UK financial regulator has fined Sir Christopher Gent £80,000 for “unlawfully” disclosing insider information in his former role as chair of medical equipment maker ConvaTec. Gent is a...
The FCA has recently fined Sir Christopher Gent, former non-executive Chairman of a global medical products and technologies company (the Company), £80,000 for the unlawful disclosure of inside information relating to the Company in contravention of the EU Market Abuse Regulation (EU MAR)
5 ago 2022 · Mark Sweney. Fri 5 Aug 2022 08.20 EDT. Sir Christopher Gent, the former chief executive of Vodafone and ex-chair of GlaxoSmithKline, has been fined £80,000 by the UK financial watchdog for...
5 ago 2022 · The Financial Conduct Authority has fined Sir Christopher Gent, former non-executive Chairman of ConvaTec Group Plc, £80,000 for unlawfully disclosing inside information. While Chairman, Sir Christopher disclosed inside information to individuals in senior positions at two of ConvaTec’s major shareholders before this information ...
